Synthgene Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

Synthgene General Information

Description

Manufacturer of life sciences raw materials designed to support research and development in biotechnology and molecular medicine. The company offers nucleic acid drug materials, cell and gene therapy inputs, immunodiagnostic materials, and mRNA-related reagents supported by advanced platforms such as antibody discovery and enzyme evolution, enabling biotechnology companies, research institutions, and diagnostic developers to accelerate therapeutic development and improve research efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 7, Yiyao Health Technology Park, Number 63 Science and Technology Avenue
  • Gaocheng Town, Yixing
  • Wuxi, Jiangsu
  • China
+86 400
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Building 7, Yiyao Health Technology Park, Number 63 Science and Technology Avenue
  • Gaocheng Town, Yixing
  • Wuxi, Jiangsu
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthgene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 23-Mar-2026 Completed Generating Revenue
7. Later Stage VC (Series B1) 26-Mar-2025 Completed Generating Revenue
6. Secondary Transaction - Private 20-Dec-2024 Completed Generating Revenue
5. Later Stage VC (Series B) 20-Dec-2024 Completed Generating Revenue
4. Secondary Transaction - Private 02-Jun-2023 Completed Generating Revenue
3. Early Stage VC (Series A1) 21-Mar-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 21-Oct-2021 $31M $31M Completed Generating Revenue
1. Early Stage VC 30-Jun-2021 Completed Generating Revenue
To view Synthgene’s complete valuation and funding history, request access »

Synthgene Patents

Synthgene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026026951-A1 Bvdv-ibrv bivalent mrna vaccine and use thereof Pending 02-Aug-2024
WO-2025185690-A1 Platinum compound and use thereof Pending 07-Mar-2024
WO-2025185690-A8 Platinum compound and use thereof Pending 07-Mar-2024
WO-2025168058-A1 Novel mrna capping compound and use thereof Pending 08-Feb-2024
EP-4768492-A1 Capping compound, and application thereof in mrna capping Pending 26-Sep-2023 C07H19/207
To view Synthgene’s complete patent history, request access »

Synthgene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthgene Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
S&G Investment Venture Capital Minority
Leader Venture Capital Growth/Expansion Minority
Granite Asia Venture Capital Minority
HaoYue Capital Investment Bank Minority
Suzhou Yuanfeng Capital Management Government Minority
You’re viewing 5 of 14 investors. Get the full list »

Synthgene Investments (1)

Synthgene’s most recent deal was a Early Stage VC with Xingchen Zhiyao. The deal was made on 17-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xingchen Zhiyao 17-Mar-2023 Early Stage VC Drug Discovery
To view Synthgene’s complete investments history, request access »

Synthgene FAQs

  • When was Synthgene founded?

    Synthgene was founded in 2018.

  • Where is Synthgene headquartered?

    Synthgene is headquartered in Wuxi, China.

  • What is the size of Synthgene?

    Synthgene has 22 total employees.

  • What industry is Synthgene in?

    Synthgene’s primary industry is Biotechnology.

  • Is Synthgene a private or public company?

    Synthgene is a Private company.

  • What is Synthgene’s current revenue?

    The current revenue for Synthgene is .

  • How much funding has Synthgene raised over time?

    Synthgene has raised $46.8M.

  • Who are Synthgene’s investors?

    S&G Investment, Leader Venture Capital, Granite Asia, HaoYue Capital, and Suzhou Yuanfeng Capital Management are 5 of 14 investors who have invested in Synthgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process